|
ITG has set up a series of competencies for the purpose of aiding
our customers/collaborators in the development of pharmaceuticals.
The scientific staff at ITG has extensive
experience in the development of radiopharmaceuticals,
particularly bone-seeking radiopharmaceuticals.
Additionally, we have experience designing antibody conjugates
for radioimmunotherapy.
Our model is to house the necessary capabilities under one roof
to shorten the development time for drug
candidates. Capabilities include synthetic organic and chelation
chemistry, with particular expertise in bifunctional chelants
for radiolabeling proteins. Additional capabilities
include radioanalytical and radiochemistry, with expertise in diagnostic
and therapeutic isotopes. Small animal testing
capabilities include the ability to perform biodistribution and
pharmacokinetic studies on normal and tumor xenograft models
using radiolabeled compounds.
|